Dr Andrea De Censi talks to ecancer at MBCC 15 about selective oestrogen receptor modulators (SERMS) and tamoxifen, as well as a number of phase III double blind trials.
Dr De Censi discusses how there are very effective drugs for breast cancer prevention, but the medical community is still...
Published 07/19/13